Passage Bio, Inc. (PASG) Tops Q3 EPS by 29c

Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.29 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
• Canaccord Starts L1 Group Ltd (L1G:AU) at Buy